Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Engelmann

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Nucleic Acids Research|September 10, 2015
Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signaturesYajie Wang, Vijay Alla, Deborah Goody, et al.
Journal of the National Cancer Institute|December 23, 2009
E2F1 in melanoma progression and metastasisVijay Alla, David Engelmann, Annett Niemetz, et al.
The Journal of Urology|February 21, 2016
Integrated Loss of miR-1/miR-101/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient OutcomeJuliane M Hartz, David Engelmann, Katharina Fürst, et al.
Nature Communications|August 5, 2017
Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signaturesFaiz M Khan, Stephan Marquardt, Shailendra K Gupta, et al.
Journal of Molecular Cell Biology|September 10, 2013
E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-BDavid Engelmann, Deborah Mayoli-Nüssle, Christian Mayrhofer, et al.
Cancer Letters|November 17, 2018
DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progressionKatharina Fürst, Marc Steder, Stella Logotheti, et al.
Cancer Cell|October 19, 2013
DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signalingMarc Steder, Vijay Alla, Claudia Meier, et al.
Theranostics|September 1, 2020
LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1Stella Logotheti, Stephan Marquardt, Shailendra K Gupta, et al.
Theranostics|March 15, 2019
Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic CancersDeborah Goody, Shailendra K Gupta, David Engelmann, et al.
Nature|July 14, 2015
Comprehensive genomic profiles of small cell lung cancerJulie George, Jing Shan Lim, Se Jin Jang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nucleic Acids Research|September 10, 2015
Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signaturesYajie Wang, Vijay Alla, Deborah Goody, et al.
Journal of the National Cancer Institute|December 23, 2009
E2F1 in melanoma progression and metastasisVijay Alla, David Engelmann, Annett Niemetz, et al.
The Journal of Urology|February 21, 2016
Integrated Loss of miR-1/miR-101/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient OutcomeJuliane M Hartz, David Engelmann, Katharina Fürst, et al.
Nature Communications|August 5, 2017
Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signaturesFaiz M Khan, Stephan Marquardt, Shailendra K Gupta, et al.
Journal of Molecular Cell Biology|September 10, 2013
E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-BDavid Engelmann, Deborah Mayoli-Nüssle, Christian Mayrhofer, et al.
Cancer Letters|November 17, 2018
DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progressionKatharina Fürst, Marc Steder, Stella Logotheti, et al.
Cancer Cell|October 19, 2013
DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signalingMarc Steder, Vijay Alla, Claudia Meier, et al.
Theranostics|September 1, 2020
LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1Stella Logotheti, Stephan Marquardt, Shailendra K Gupta, et al.
Theranostics|March 15, 2019
Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic CancersDeborah Goody, Shailendra K Gupta, David Engelmann, et al.
Nature|July 14, 2015
Comprehensive genomic profiles of small cell lung cancerJulie George, Jing Shan Lim, Se Jin Jang, et al.
Pageof 2